Former Minister of Health, Labour and Welfare, Norihiro Tamura, to Speak at Ubie Pharma Summit 2026

Ubie Corporation (Headquarters: Chuo-ku, Tokyo; Co-CEOs: Yoshinori Abe, Kota Kubo), whose mission is to "guide people to appropriate medical care with technology," is pleased to announce that Norihiro Tamura, a member of the House of Representatives and former Minister of Health, Labour and Welfare, has been confirmed as a speaker at the "Ubie Pharma Summit 2026," a conference for pharmaceutical companies where Ubie Corporation participates as an executive committee member. The summit will be held in Tokyo on May 13-14, 2026. ■ About "Ubie Pharma Summit" The "Ubie Pharma Summit" is a conference for pharmaceutical companies organized by the Ubie Pharma Summit Executive Committee. It aims to contribute to the further development of the industry by bringing together top leaders and innovators to deepen discussions on medium- to long-term problem-solving and the future of healthcare. This year, with "Integration" as its keyword, the summit focuses on the "silos" that exist across various layers of the pharmaceutical industry, including regulatory systems, clinical settings, and technology. It proposes a new concept of seamlessly "stitching together" these divisions from a patient-centric perspective, utilizing the innovative power of AI and the latest information technology. The goal is to fundamentally eliminate the countless "frictions" patients encounter in diagnosis and treatment processes, aiming for the implementation of a truly "patient-centric world," and creating a platform for cross-industry collaboration. ■ About the Speakers *In alphabetical order Reiko Akizuki: Executive Officer/Head of Medical Affairs, Amgen K.K. Wakato Ishida: Head of Alliance Immunology, Respiratory/Rhinology Medical Department, Specialty Care Medical Division, Sanofi K.K. Takahiko Iwaya: Representative Director and President, Sanofi K.K.; Chairman, European Federation of Pharmaceutical Industries and Associations (EFPIA Japan) Shizuko Ueno: Director, Japan Business Unit Head, Japan Business Unit Head & Head of Medical Affairs, Daiichi Sankyo Co., Ltd. Osamu Okuda: Representative Director, President & CEO, Chugai Pharmaceutical Co., Ltd. Masataka Ogimura: Representative Director, President of Pharmaceutical Business Unit, Boehringer Ingelheim Japan, Inc. Hidenori Katsuma: Representative Director and President, Bristol-Myers Squibb K.K. Jeremy Grossas: Representative Director and President, Merck Biopharma K.K. Simone Thomsen: Representative Director and President, Eli Lilly Japan K.K. John D. Halamka: Dwight and Dian Diercks President, Mayo Clinic Platform Jean-Paul Prisyano: Representative Director and President, Novartis Pharma K.K. Susana Murteira: Representative Director and President, Amgen K.K. Norihiro Tamura: Member of the House of Representatives, Former Minister of Health, Labour and Welfare Koyuki Den: Bio